No Data
Candel Therapeutics Advances in Cancer Treatment Trials
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC)
Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End | NASDAQ:CADL
Daily options tracking | Nvidia's stock price hit a three-month high, with the highest increase in call options nearly tripling; China concept ETF cools down, with a significant decrease in volatility.
tesla rose slightly by 1.52%, the call options with expiration dates of this Friday at 245 and 250 US dollars were the most active, Robotaxi conference tickets have been issued, the event is scheduled for 10 am this Friday morning peking time.
This Insider Has Just Sold Shares In Candel Therapeutics
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting
No Data
No Data